PRF1 and breast cancer: demonstrated that anti-PD-1 treatment activates NKT and dendritic cells in a same murine breast cancer model, by increasing the expression of tumoricidal molecules such as perforin and promoting M1 polarization of TAMs, leading to overall tumour growth deceleration [43].